menu search

Miromatrix ceo jeff ross to present at the 2023 cell & gene meeting on the med

EDEN PRAIRIE, Minn., April 10, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a ...

April 10, 2023, 7:01 am

Netflix (nflx) expands international content with stolen

Netflix (NFLX) is expanding international content with the adaptation of Ann-Helen Laestadius??? novel, Stolen, starring Elin Kristina Oskal in the le...

April 6, 2023, 4:00 pm

Respirerx pharmaceuticals highlights analogs of its anti-seizure treatment in scientific publications

RespireRx Pharmaceuticals (OTC:RSPI) Inc has announced the publication of four articles describing the pharmacological activity of ...

April 3, 2023, 10:06 am

Kineta to present at 22nd annual needham healthcare conference

SEATTLE, April 03, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of ...

April 3, 2023, 6:30 am

Cgdv: underperformed since previous note, valuation risks in place, rating maintained

CGDV is a relatively novel actively managed fund targeting attractively priced stocks capable of return...

April 2, 2023, 11:49 am

Predictive oncology partners with integra therapeutics to advance gene therapy

Predictive Oncology Inc. (NASDAQ:POAI) said it is partnering with Integra Therapeutics, a company focused on engineering the next generation of gene w...

March 30, 2023, 9:25 am

Cns pharmaceuticals to present at the virtual investor gbm spotlight event

Live moderated video webcast with members of CNS Pharmacetucals management and Key Opinion Leader, Professor Michael Weller, MD, on Tuesday, April 4 t...

March 29, 2023, 9:05 am

Infinity stone announces formation of aircarbon subsidiary for rockstone graphite project; partners with r&d innovations for novel graphite processing technology

Infinity Stone Ventures Corp (CSE:GEMS, OTC:GEMSF) has announced the formation of a new wholly-owned subsidiary, AirCarbon Technology Corp, to develop...

March 29, 2023, 7:42 am

Here's why viking therapeutics rose over 50% on obesity drug data

Clinical-stage biotechnology company Viking Therapeutics, Inc. (NASDAQ: VKTX) stock jumped more than 50% on positive Phase 1 data on its ...

March 28, 2023, 1:01 pm

Mindset pharma ceo discusses expansion of drug discovery efforts into novel non-hallucinogenic therapeutics

Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF). is expanding its drug discovery efforts into novel non-hall...

March 28, 2023, 8:51 am

Biomx to host fourth quarter and full year 2022 financial results conference call and webcast on march 29th, 2023

CAMBRIDGE, Mass. and NESS ZIONA, Israel, March 27, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a cli...

March 27, 2023, 7:00 am

Aclaris therapeutics to participate in the h.c. wainwright autoimmune & inflammatory disease virtual conference

WAYNE, Pa., March 27, 2023 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on develo...

March 27, 2023, 7:00 am

Verona's ensifentrine: a promising novel treatment for copd patients

Verona Pharma's ensifentrine is a first-in-class, inhaled, dual inhibitor of the enzymes PDE3 and PDE4, targeting both bronchodilation and inflammatio...

March 27, 2023, 2:31 am

Generation bio, moderna announce collaboration

Shares of Generation Bio Co. GBIO, -0.51% jumped about 28% premarket trading on Thursday after the company announced a collaboration with Moderna Inc....

March 23, 2023, 7:44 am

Lobe sciences partner gets dea quota to produce psilocin drug for two studies

Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBED) announced that its exclusive commercial manufacturing partner has received an initial 2023 quota for the com...

March 22, 2023, 11:01 am

Kineta to present vista biomarker data at aacr annual meeting 2023

SEATTLE, March 22, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of ...

March 22, 2023, 6:30 am

Spectrum pharmaceuticals to report fourth quarter and full year 2022 financial results and provide corporate update

BOSTON--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on ...

March 17, 2023, 7:00 am

Ventyx biosciences to report fourth quarter and full year 2022 financial results on march 23, 2023

ENCINITAS, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”), a clinical-stage biopharmaceutical comp...

March 15, 2023, 4:05 pm

Xencor to present preclinical data from novel xmab® cd28 bispecific antibody programs at the american association for cancer research annual meeting 2023

PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokin...

March 14, 2023, 4:31 pm

Monoclonal antibodies? avid bioservices surges 32% on blowout q3

Avid Bioservices Inc. (NASDAQ: CDMO) is a contract development and manufacturing organization (CDMO) that specializes in producing monoclonal antibodi...

March 14, 2023, 1:12 pm


Search within

Pages Search Results: